Letters to a Series of Covered Entities Participating in the 340B Drug Pricing Program
Excerpt: “… 2014 study by the Office of Inspector General at the U.S. Department of Health and Human Services found that not all covered entities ensure that uninsured patients benefit from the discounted 340B prices at their contract pharmacies.”
To read a copy of the letter to ARcare, click here.
To read ARcare's response, click here.
To read a copy of the letter to Cedars-Sinai Medical Center, click here.
To read Cedars-Sinai Medical Center's response, see Part 1, Part 2, Part 3, and Part 4.